{"schema_version":"1","generated_at":"2026-11-07T22:56:52.205Z","data_as_of":null,"url":"https://www.findmykol.com/kol/jeffrey-pu","json_url":"https://www.findmykol.com/kol/jeffrey-pu/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"jeffrey-pu","name":"Jeffrey Pu","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Hershey","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1831399708","orcid":"0000-0001-7498-3159","openalex":"A5028299420"},"summary":"Jeffrey Pu is an Oncology physician. OpenAlex indexes 110 publications with 2,910 citations (h-index 22); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":110,"cited_by_count":2910,"h_index":22,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01439750","title":"Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)","phase":"PHASE1","status":"UNKNOWN","role":"Overall official","sponsor":"Milton S. Hershey Medical Center","source_url":"https://clinicaltrials.gov/study/NCT01439750","trial_url":"https://www.findmykol.com/trial/NCT01439750"}],"source":"trials"},"payments":{"company_count":18,"program_years":{"first":2021,"last":null},"rows_total":34,"shown":3,"withheld":31,"rows":[{"payer":"Janssen Scientific Affairs, LLC","program_year":2025,"amount_usd":150,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1831399708"},{"payer":"Stemline Therapeutics Inc.","program_year":2025,"amount_usd":131.44,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1831399708"},{"payer":"Pfizer","program_year":2024,"amount_usd":20045.26,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1831399708"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1831399708","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"American Society of Hematology 2026 guidelines for frontline management of acute lymphoblastic leukemia in adolescents and young adults","year":2026,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2021006469","status":"verified"},{"title":"Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation","year":2024,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2024.07.009","status":"verified"},{"title":"Preclinical evaluation of CD70-specific CAR T cells targeting acute myeloid leukemia","year":2023,"journal":"Frontiers in Immunology","source_url":"https://doi.org/10.3389/fimmu.2023.1093750","status":"verified"},{"title":"A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis","year":2023,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2023009886","status":"verified"},{"title":"Acute myeloid leukemia cells and MSC-derived exosomes inhibiting transformation in myelodysplastic syndrome","year":2023,"journal":"Discover Oncology","source_url":"https://doi.org/10.1007/s12672-023-00714-2","status":"verified"}],"source":"works"},"contact":{"address_1":"500 UNIVERSITY DR","city":"Hershey","state":"PA","zip":"170332360","phone":"800-243-1455","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1831399708","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":31,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2012-07-27","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}